Ibrilparant
Ibrilparant is a LPA1 receptor antagonist with an IC50 of 0.00753 μM. Ibrilparant exhibits LPA1 calcium flux antagonistic activity, with an IC50 of 3.02 nM. Ibrilparant can be used in research related to various diseases such as cancer and inflammatory diseases.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2978107-47-8
- Fòrmula: C25H31NO5
- Peso molecular:425.52
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
|
LPA1 Receptor |
Ibrilparant (compound 355) exerts potent functional antagonistic activity against LPA1 in CHO-K1 cells overexpressing human LPA1 and G15a, with an IC50 of 0.00753 μM[1].
Ibrilparant exhibits potent LPA1 calcium flux antagonistic activity in CHO-K1 cells overexpressing human LPA1 and G15a, with an IC50 of 3.02 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 2978107-47-8
-
Peso molecular 425.52
-
Fòrmula C25H31NO5
-
SMILES
O=C(C1(CCOCC1)NC2=CC=C(C(COC3CC3)=C2)C4=C(C)C(OCC)=CC=C4)O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz